EXECUTIVE SEARCH · CEO · HEALTHCARE · NEW YORK

Top CEO Executive Search
Healthcare · New York

Retained CEO search for New York academic medical centres, integrated-delivery networks, listed managed-care operators and PE-backed healthcare-services platforms anchored across Midtown, the Upper East Side hospital corridor and Long Island City — partner-led, public-trust architects.

Brief Us On A Mandate See Our Process

120+

CXO Mandates Closed

Last 24 months, global

94%

On-Shortlist Retention

After first slate

95–120 Days

Time-to-Placement

Typical retained mandate

12 Months

Candidate Guarantee

Replacement included

The Combo

What a CEO Healthcare mandate looks like in New York

A CEO mandate at a New York-anchored healthcare entity is a public-trust and integrated-delivery-network stewardship seat before it is a P&L seat. The successful candidate carries quarterly dialogue with the CMS Administrator's office on rate-cycle and Medicare-negotiation programmes, navigates the New York State Department of Health certification framework that shapes integrated-delivery-network capital deployment, holds credible engagement with the HHS Secretary's office and the New York Attorney General's healthcare-charities division for academic medical centre mandates, and reads Congressional Energy and Commerce Committee scrutiny as material to the share price on a single hearing. New York anchors a distinctive healthcare concentration: academic medical centres with national patient-and-research franchises, integrated-delivery networks consolidating acute-care, ambulatory and post-acute estates across the metro, listed managed-care operators facing quarterly equity-market scrutiny, and PE-backed healthcare-services platforms consolidating specialty diagnostics, revenue-cycle management and clinical-research services. The talent map clusters across Midtown where listed managed-care CEO benches concentrate, the Upper East Side hospital corridor where academic medical centre and integrated-delivery-network CEO offices sit, and Long Island City where PE-backed healthcare-services CEO benches have built.

What shapes our calibration differently for this combo is the public-trust governance and the integrated-delivery-network capital-deployment architecture. Tier-1 NYC healthcare CEO packages typically land USD 1.0M–1.8M base + 100–180% short-term incentive + multi-year performance-share vesting tied to operating-margin defence, payor-mix metrics and free-cash-flow conversion; academic medical centre CEOs operate at USD 800K–1.4M base anchored to mission-aligned governance; PE-backed healthcare-services CEOs trade cash for milestone-tied equity on the exit window. We over-index on operators who have closed an integrated-delivery-network capital-deployment cycle, owned a CMS rate-cycle defence at managed-care scale, or led an academic medical centre strategic-portfolio reshape through state Department of Health scrutiny. The India angle is materially distinctive at CEO level: board-level South-Asia diaspora-health-corridor strategy, India clinical-trial outsourcing as a strategic capital-allocation decision, and cross-border specialty-services franchise work are now standard line items on the calibration call.

CEO × Healthcare

How the CEO seat reads inside Healthcare

Compensation Benchmark

Listed-pharma, medical-device and integrated-healthcare CEO compensation typically lands USD 1.0M–2.0M base + 100–200% short-term incentive + multi-million-dollar performance-share vesting tied to pipeline progress and revenue defence. Academic-medical-centre CEOs operate at USD 700K–1.4M base anchored to mission-aligned governance; PE-backed healthcare-services CEOs trade cash for milestone-tied equity on the exit window.

Typical Mandate Length

130–160 days

Operator who has owned pipeline-and-commercial strategy through at least one FDA cycle, navigated CMS rate-cycle defence at board reporting cadence, and held credible dialogue with the FDA Commissioner's office, the CMS Administrator, and—for academic medical centres—state DPH and federal HHS counterparts. Strong slates over-index on operators who have led a strategic carve-out, IPO or PE-backed restructuring alongside pipeline ownership rather than only steady-state commercial operations.

Industry-specific KPIs

Pipeline progression and R&D capital allocation
Drug-pricing narrative and Inflation Reduction Act negotiation posture
Payor-mix architecture and CMS reimbursement defence
Board, FDA Commissioner and Congressional stakeholder management
Top-team succession and commercial-operating-committee bench

Healthcare × New York

Healthcare ecosystem in New York

Content TBD — Pending P2

The Healthcare × New York ecosystem note (anchor districts, regulator emphasis, talent depth) will be authored in P2.

Cost Structure

Wall-Street-grade rigor. India-based cost structure.

Our research desk and senior partners operate from India, which means our retainer carries a different overhead curve than a Park Avenue boutique. The output you see — the calibration memo, the slate, the assessment dossiers, the partner who runs the search — is identical to what you would receive from a global retained firm. The economics are not.

Proof

Senior partner on every search

The named partner runs the longlist, the approach, and the offer — the work is never quietly delegated to a coordinator.

Proof

12-month replacement

If the placed candidate departs in the first twelve months, we re-run the search at no additional retainer.

Proof

No outsourced research

The talent map is built in-house by our research desk; we do not buy lists or rent offshore sourcing pods.

Typically 30–45% lower retainer than equivalent Manhattan or Stamford boutiques

The Process

Six steps. One discipline.

Our six-step retained search process for CEO mandates in Healthcare, anchored in New York. Same calibration discipline as a standalone city mandate, narrowed to the function and sector by the calibration memo.

Mandate Calibration

We read the operating cadence between your headquarters and the markets the leader will serve, then convert the brief into a written calibration memo with the success measures the slate will be judged against.

Week 1

Talent-Map Build

Our research desk constructs a city-anchored talent map covering incumbents at the role plus high-potential next-rung candidates. The map is shared before approach begins, so you see which lanes we hunt and which we skip.

Weeks 1–2

Targeted Approach

A senior partner approaches the longlist personally, off-platform, with the same discretion the role itself will demand of its eventual holder. We never publish the search.

Weeks 2–4

Assessment & Calibration

Each candidate is evaluated against the calibration memo. Structured references and a written assessment dossier are shared with your selection committee — no candidate enters the slate without one.

Weeks 4–7

Slate & Selection

We present a five-name shortlist with a slate ranking, an attempt-to-hire view, and the trade-offs we would accept or reject ourselves. The committee meets the slate; we do not.

Weeks 6–9

Offer & Onboarding Bridge

We carry the offer construction, manage the resignation runway, and stay engaged through the first hundred days. The 12-month replacement guarantee runs from the candidate's start date.

Weeks 8–12+

FAQs

Frequently asked — CEO Healthcare mandates in New York

Answers to the questions boards most often ask before retaining a search partner for a CEO Healthcare mandate anchored in New York.

One hundred thirty to one hundred sixty days from calibration memo to signed offer. Academic medical centre and integrated-delivery-network searches run longer because mission-aligned governance and state Department of Health reference cycles are heavier; listed managed-care searches tighten on rating-agency reference work at the back end.

Direct dialogue history with the CMS Administrator's office on at least one rate-cycle or Medicare-negotiation programme, paired with credible New York State Department of Health certification engagement. CEOs whose only regulatory engagement is delegated through senior policy staff rarely clear the comparator review at a Tier-1 NYC mandate.

NYC integrated-delivery-network CEOs own multi-site capital deployment across acute-care, ambulatory and post-acute estates under New York State Department of Health oversight. Boston academic medical centre CEOs anchor on mission-aligned governance alongside operating-margin discipline under a research-and-teaching-intensive frame and HHS Secretary's office engagement. Comparator pools differ structurally.

Viable across listed managed-care, integrated-delivery-network and PE-backed healthcare-services CEO seats. The Mumbai–New York and Hyderabad–New York corridors move senior commercial bench through cross-border specialty-services and clinical-research franchise work; academic medical centre CEO seats still privilege local NYC-comparator and academic-alumni networks.

Engage

Brief us on a CEO Healthcare mandate in New York

Conversations are confidential, partner-led, and carry no obligation to retain. A senior practice partner reviews every enquiry personally and responds within four business hours.